
AI-generated digital twins that make clinical trials smaller, faster, and more informative
AI-generated digital twins that make clinical trials smaller, faster, and more informative
AI-powered probability-of-success analytics for clinical drug development
Estimated monthly website visits
Similarweb estimates for this domain, not active users. Only available observation months are shown; collection date is separate from the traffic period.
Collected Nov 11, 2026

This is our editors' assessment out of 5, not an average of user ratings. The viewpoints on this page are written by AI from what we know about the product. They are not customer reviews.
According to OpenAITools.app telemetry verified on 2026-11-11, Intelligencia AI (intelligencia.ai) is an AI platform indexed under AI Healthcare generating 3.87K monthly visits with a month-over-month traffic delta of -1.81K (-31.9%). Its primary geographic market is United States (69.5% traffic share), and it operates on a Contact for Pricing pricing model. Top competing alternatives by monthly volume include Unlearn.AI (17.11K visits/mo), Dr.Oracle (723.85K visits/mo), Floatz (253 visits/mo).
Game changer for de-risking clinical trial pipelines. Worth every penny for pharma strategists.
PTRS predictions are remarkably accurate compared to historical benchmarks.
Data ingestion takes some time, but portfolio insights are gold.
Enterprise pricing is opaque, need to talk to sales for everything.
AI-synthesized perspectives grounded in live site inspection, pricing structure, and category benchmarks — presented as editorial viewpoints rather than individual customer testimonials.
Model-generated likelihood-of-success assessments for drug candidates across multiple therapeutic areas, validated both retrospectively and prospectively.
Hundreds of dimensions of transparency reveal which underlying technical, regulatory, and competitive factors are moving a prediction up or down.
Competitive landscape benchmarking that helps teams spot predictive signals and compare their programs against the wider pipeline.
Tools for reviewing risk across an entire pipeline and standardising risk evaluation so assets can be compared consistently.
A single source of harmonised, quality-controlled clinical program data organised by proprietary ontologies and maintained by biomedical specialists.
Intelligencia AI sits at the intersection of biomedical data curation and applied machine learning, serving the people who decide which drug programs get funded, licensed, or shelved. Instead of relying on legacy benchmarks or anecdotal experience, teams can query model-driven probability-of-success estimates that are organised by therapeutic area and validated both retrospectively and prospectively.
The platform's core products include a Portfolio Optimizer for comparing and balancing assets, Dynamic Benchmarks for competitive landscape analysis, and a Data & Insights layer built on proprietary ontologies. Because trust matters in regulated industries, the company emphasises explainability: predictions come with transparency into which features drove the algorithm's output, so analysts can answer both the "how" and the "why" behind a score.
Intelligencia AI is aimed at enterprise pharma organisations — the company states that many of the top global pharmaceutical companies work with it — rather than individual users. Access is arranged through a demo request, and pricing is quoted per engagement rather than published as a self-serve subscription.
Rank and rebalance internal programs using consistent risk scores rather than fragmented, team-by-team judgement.
Assess the technical and regulatory risk profile of external assets before committing to a deal or partnership.
Identify risk drivers early and feed those signals into protocol design and endpoint selection.
Use Dynamic Benchmarks and curated pipeline data to monitor emerging trends and competitor movement.
Side-by-side telemetry comparison of competing AI tools in the same primary category
| Rank | AI Tool | Monthly Visits | MoM Growth | Direct traffic share | Pricing | Head-to-Head |
|---|---|---|---|---|---|---|
| ● | Intelligencia AI | 3.87K | -31.9% | 27% direct | Contact for Pricing | Current |
| 1 | Unlearn.AI | 17.11K | -32.5% | 44% direct | Contact for Pricing | vs Unlearn.AI |
| 2 | Dr.Oracle | 723.85K | -1.2% | 12% direct | Free Trial | vs Dr.Oracle |
| 3 | Floatz | 253 | -36.8% | 37% direct | Contact for Pricing | vs Floatz |
| 4 | FutureSearch | 34.47K | -32.7% | 42% direct | Freemium | vs FutureSearch |
| 5 | Cradle | 16.99K | -22.3% | 37% direct | Contact for Pricing | vs Cradle |
| 6 | RapidAI | 20.17K | -27.9% | 45% direct | Contact for Pricing | vs RapidAI |

AI-generated digital twins that make clinical trials smaller, faster, and more informative
AI-generated digital twins that make clinical trials smaller, faster, and more informative
Free / Open-sourceGuideline-directed medical answers with citations, built for clinicians
Free / Open-sourceGuideline-directed medical answers with citations, built for clinicians

AI-driven scientific due diligence for biotech investors
AI-driven scientific due diligence for biotech investors

Free / Open-sourceCalibrated forecasts with the evidence trail attached
Free / Open-sourceCalibrated forecasts with the evidence trail attached

Engineer better proteins, faster, with AI

Enterprise clinical AI that turns medical imaging into faster, more confident care decisions.
Enterprise clinical AI that turns medical imaging into faster, more confident care decisions.

Free / Open-sourceAI-driven stock scores that rank every pickable stock by probability of beating the market
Free / Open-sourceAI-driven stock scores that rank every pickable stock by probability of beating the market

AI lung cancer screening that finds eligible patients and scores every nodule
AI lung cancer screening that finds eligible patients and scores every nodule

Clinician-led AI safety evaluation and psychosocial risk benchmarking
Clinician-led AI safety evaluation and psychosocial risk benchmarking

AI-powered ECG interpretation and precision cardiology at scale

Free / Open-sourceAI-powered resident care platform for senior living
Free / Open-sourceAI-powered resident care platform for senior living